Downregulation of MHC class I molecules on cancer cells can lead to their elimination by NK cells if the target cells express ligands for stimulatory NK cell receptors, such as NKG2D ligands (MICA-B, ULBPs 1–5). This evidence concerns the gene KLRK1 and cancer.